TECX (Tectonic Therapeutic) Net Cash per Share : $8.69 (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Tectonic Therapeutic Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Tectonic Therapeutic's Net Cash per Share for the quarter that ended in Dec. 2024 was $8.69.

The historical rank and industry rank for Tectonic Therapeutic's Net Cash per Share or its related term are showing as below:

TECX' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 2.37 Med: 5.31 Max: 5.31
Current: 2.39

During the past 4 years, the highest Price-to-Net-Cash Ratio of Tectonic Therapeutic was 5.31. The lowest was 2.37. And the median was 5.31.

TECX's Price-to-Net-Cash is ranked better than
65.48% of 846 companies
in the Biotechnology industry
Industry Median: 3.795 vs TECX: 2.39

Tectonic Therapeutic Net Cash per Share Historical Data

The historical data trend for Tectonic Therapeutic's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tectonic Therapeutic Net Cash per Share Chart

Tectonic Therapeutic Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Net Cash per Share

-1.34

-3.86

-6.47

8.69

Tectonic Therapeutic Quarterly Data
	Dec21	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
Net Cash per Share	Get a 7-Day Free Trial			-6.06	-6.47	10.70	9.55	8.69

Competitive Comparison of Tectonic Therapeutic's Net Cash per Share

For the Biotechnology subindustry, Tectonic Therapeutic's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tectonic Therapeutic's Price-to-Net-Cash Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tectonic Therapeutic's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Tectonic Therapeutic's Price-to-Net-Cash falls into.

Save Embed

;

Save Embed

;

Tectonic Therapeutic Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Tectonic Therapeutic's Net Cash per Share for the fiscal year that ended in Dec. 2024 is calculated as

	Net Cash per Share (A: Dec. 2024 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(141.239	-	12.129	-	0)	/	14.856
=	8.69

Tectonic Therapeutic's Net Cash per Share for the quarter that ended in Dec. 2024 is calculated as

	Net Cash per Share (Q: Dec. 2024 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(141.239	-	12.129	-	0)	/	14.856
=	8.69

Tectonic Therapeutic (NAS:TECX) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.

Tectonic Therapeutic Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Tectonic Therapeutic's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Tectonic Therapeutic Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tectonic Therapeutic Inc (NAS:TECX) » Definitions » Net Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

490 Arsenal Way, Suite 210, Watertown, MA, USA, 02472

Website

https://www.tectonictx.com

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.